Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor Activity

Molecular Cancer Therapeutics
Jae-Cheol JoTae Won Kim

Abstract

The MET receptor tyrosine kinase, the receptor for hepatocyte growth factor (HGF), has been implicated in cancer growth, invasion, migration, angiogenesis, and metastasis in a broad variety of human cancers, including human hepatocellular carcinoma (HCC). Recently, MET was suggested to be a potential target for the personalized treatment of HCC with an active HGF-MET signaling pathway. However, the mechanisms of resistance to MET inhibitors need to be elucidated to provide effective treatment. Here, we show that HCC cells exhibit different sensitivities to the MET inhibitor PHA665752, depending on the phosphorylation status of FGFR. Treatment of cells expressing both phospho-FGFR and phospho-MET with the inhibitor PHA665752 did not cause growth inhibition and cell death, whereas treatment with AZD4547, a pan-FGFR inhibitor, resulted in decreased colony formation and cleavage of caspase-3. Moreover, silencing of endogenous FGFR1 and FGFR2 by RNAi of HCC cells expressing phospho-FGFR, phospho-FGFR2, and phospho-MET overcame the resistance to PHA665752 treatment. Treatment of primary cancer cells from patients with HCC expressing both phospho-FGFR and phospho-MET with PHA665752 did not induce cell death, whereas AZD4547 treatment ...Continue Reading

References

Jul 30, 2003·Cancer Metastasis Reviews·Patrick C MaRavi Salgia
May 3, 2005·Cytokine & Growth Factor Reviews·Richard Grose, Clive Dickson
Sep 9, 2005·World Journal of Gastroenterology : WJG·Wei-Hua QiuYun Yen
Sep 28, 2005·Proceedings of the National Academy of Sciences of the United States of America·Vikki RandRobert L Strausberg
May 20, 2006·The Journal of Clinical Investigation·Pal Kaposi-NovakSnorri S Thorgeirsson
Jun 16, 2007·Gastroenterology·Hashem B El-Serag, K Lenhard Rudolph
Jun 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Amit DuttHeidi Greulich
Nov 26, 2010·Nature Reviews. Molecular Cell Biology·Livio TrusolinoPaolo M Comoglio
Feb 26, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Joong-Won ParkJean-Luc Raoul
May 28, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hanning YouC Bart Rountree
Jul 5, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Sonia GatiusXavier Matias-Guiu
Jan 13, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Richard S FinnJoong-Won Park
Jan 26, 2012·Biochimica Et Biophysica Acta·Imran AhmadHing Y Leung
May 23, 2012·PloS One·Dorothy M FrenchLuc R Desnoyers
Aug 28, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip J JohnsonAnn-Lii Cheng
Aug 28, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Josep M LlovetJoong-Won Park
Jun 14, 2014·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Kimberly J RiehleRaymond S Yeung

❮ Previous
Next ❯

Citations

Jul 3, 2020·Chemistry : a European Journal·Kuiling DingZhaobin Han
Sep 11, 2018·World Journal of Gastroenterology : WJG·Javier A García-Vilas, Miguel Ángel Medina
Oct 17, 2019·BMC Cancer·Heini M NatriKenneth H Buetow
Mar 3, 2020·Frontiers in Cell and Developmental Biology·Haiyu WangZujiang Yu
Feb 11, 2016·Cancer Prevention Research·Alok KhandelwalCherie-Ann O Nathan
Mar 28, 2021·NPJ Breast Cancer·Vanessa Y C SungMorag Park
Aug 11, 2021·Journal of Experimental & Clinical Cancer Research : CR·Yuanyuan ZhengChuanyong Guo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

© 2021 Meta ULC. All rights reserved